For the Inventor, By the Inventor

Enter assignee name

Boulder, CO, United States of America

Somalogic, Incorporated

USPTO Granted Patents = 75

% Expired Patents = 17.3

CIPO Patents = 1

EPO Patents = 37

Trademarks = 5

Forward Citations = 1,037

Loading Chart...

Loading Chart...

84 inventors (with patents filed for the assignee):

Larry M Gold (35 out of 191 patents)

Dominic Zichi (25 out of 26 patents)

Nebojsa Janjic (24 out of 70 patents)

4. Daniel J Schneider (22 out of 33 patents)

5. Sheri K Wilcox (14 out of 15 patents)

6. Bruce Eaton (13 out of 36 patents)

7. Chris Bock (12 out of 12 patents)

8. Urs Ochsner (10 out of 12 patents)

9. John C Rohloff (9 out of 28 patents)

10. Thale Jarvis (8 out of 22 patents)

11. Amy D Gelinas (8 out of 8 patents)

12. Daniel W Drolet (8 out of 12 patents)

13. Malti P Nikrad (8 out of 8 patents)

14. Sheela M Waugh (7 out of 7 patents)

15. Chi Zhang (7 out of 8 patents)

Core Competencies:

Biomarkers

Aptamers

Multiplexed Analyses

Cancer Diagnosis

Lung Cancer

Chronic Obstructive Pulmonary Disease

Nucleic Acid Ligands

Quantum Sensors

Nonalcoholic Fatty Liver Disease

Tuberculosis

Fluorescence Detection

Microorganisms

75 patents: Sort by Forward Citations

1. 11249080 - Proteomic assay using quantum sensors (2022-02-15),

2. 11221340 - Lung cancer biomarkers and uses thereof (2022-01-11),

3. 11208663 - Post-selex modification methods (2021-12-28),

4. 11111495 - Method for generating aptamers with improved off-rates (2021-09-07),

5. 11041866 - Pancreatic cancer biomarkers and uses thereof (2021-06-22),

6. 10927380 - Oligonucleotides comprising modified nucleosides (2021-02-23),

7. 10808251 - Nucleic acid compounds for binding growth differentiation factor 11 (2020-10-20),

8. 10670611 - Cardiovascular risk event prediction and uses thereof (2020-06-02),

9. 10648972 - Multiplexed analyses of test samples (2020-05-12),

10. 10634679 - Compounds and methods for the synthesis of 5-(N-protected-tryptaminocarboxyamide)-2'-deoxyuridine phosphoramidite for incorporation into a nucleic acid (2020-04-28),

11. 10620210 - Aptamers and diagnostic methods for detecting the EGF receptor (2020-04-14),

12. 10544419 - PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disorders (2020-01-28),

13. 10538771 - Compositions and methods for detecting microorganisms (2020-01-21),

14. 10526663 - Method of detecting a microorganism in a sample by a fluorescence based detection method (2020-01-07),

15. 10481155 - Proteomic assay using quantum sensors (2019-11-19),

SomaLogic, Incorporated is a biotechnology company dedicated to transforming healthcare through advanced protein biomarker discovery and development. They specialize in developing and commercializing breakthrough proteomic technologies to improve the understanding of human health and enable personalized medicine approaches. With their expertise in large-scale proteomics and data science, SomaLogic provides solutions for a wide range of applications, including diagnostics, drug discovery, and clinical research. Their innovative technology platform, known as SOMAscan®, enables the measurement of thousands of protein biomarkers simultaneously, leading to better insights into disease mechanisms, prediction of therapeutic response, and identification of new drug targets.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Somalogic, Incorporated

75 Patents

#26 in Boulder, CO

#104 in Colorado

#4,899 in US

#9,993 in the World

Boulder, CO, United States of America

Somalogic, Incorporated

Forward Citations = 1,037

84 inventors:

Larry M Gold (35 out of 191 patents)

Dominic Zichi (25 out of 26 patents)

Nebojsa Janjic (24 out of 70 patents)

4. Daniel J Schneider (22 out of 33 patents)

5. Sheri K Wilcox (14 out of 15 patents)

Please report any incorrect information to [email protected]

Loading…